跳至主要内容
临床试验/JPRN-UMIN000003811
JPRN-UMIN000003811已完成2 期

Reduced-intensity cord blood transplantation (RI-CBT) for refractory hematological malignancies - Reduced-intensity cord blood transplantation (RI-CBT)

agoya Blood and Marrow Transplantation Group0 个研究点目标入组 38 人开始时间: 2010年6月23日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Positive for HIV antibody and/or HBs antigen and/or HCV antibody.(2)Graft manipulation such as T-cell depletion .(3)History of administration of gemtuzumab ozogamicin within 6 month before transplantation.(4)Pregnant or during breast feeding. (5)Uncontrolled active psychiatric disease. (6)Uncontrolled active infection. (7)Allergic history to drugs used in the conditioning regimen or GVHD prophylaxis regimen. (8)Patients with severe organ dysfunction. (9)Patients suggested as ineligible by their attending physician.

研究者

发起方
agoya Blood and Marrow Transplantation Group

相似试验

进行中(未招募)
1 期
Stem cell transplantation with cord blood and mesenchymal stem cells after reduced intensity conditioning for severe forms of the blistering disease epidermolysis bullosaThe source population consists of patients referred to or within the UMC Groningen because they have diagnosed clinically and genetically severe generalized RDEB.
EUCTR2012-000605-72-NLniversitair Medisch Centrum Utrecht11
已完成
2 期
nrelated cord blood transplantation after reduced toxicity conditioning with mesenchymal stromal cell co-infusion in patients with severe epidermolysis bullosabutterfly child diseasecongenital bullous disease10014982
NL-OMON41470niversitair Medisch Centrum Utrecht11
已完成
2 期
Phase II study of cord blood transplantation using myeloablative conditioning in adult patiants (C-SHOT 0603)Acute leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome
JPRN-UMIN000000868Research Grant on Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare28
已完成
不适用
A feasibility trial of cord blood cell transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regime
JPRN-UMIN000007927Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan15
Unknown
不适用
mbilical cord blood transplantation in high-risk hematological patients using stemregenin-1 expanded hematopoietic stem cells.A feasibility study focusing on engraftment and hematopoietic recovery.single cord blood transplantationstemregenin-1 expanded hematopoietic stem cellsengraftment
NL-OMON26058Erasmus MC10